Establishment of three cisplatin-resistant endometrial cancer cell lines using two methods of cisplatin exposure
- 194 Downloads
Upon acquiring CDDP resistance, the cells tended to become small and grow in a floating state. This tendency was especially marked when using incremental exposure method. Using the incremental exposure method, a cell line obtained by isolating and culturing only adherent cells was designated EICR-Ia, and a cell line established by culturing only floating cells was designated EICR-If. A cell line obtained by the high concentration exposure method was designated EICR-II.
Upon acquiring CDDP resistance, tumor markers such as TPA and LDH increased, while proliferative capability of the cells was lowered.
The invasion capability was diminished in EICR-If cells, but was increased in EICR-Ia and EICR-II cells.
Following exposure to CDDP, the intracellular platinum concentrations were markedly elevated in EI and EICR-If cells, whereas the increase was mild in EICR-Ia and EICR-II cells and the concentration was lower than that in parent EI cells.
Studies of drug resistance gene expression revealed increased expression of MDR1, GSTπ, and Topo-II in EICR-If cells; increased expression of GSTπ in EICR-II cells; but no expression of any of the genes in EICR-Ia cells.
Analyses of cancer- and apoptosis-related genes showed increased expressions of Bcl-2, c-Myc, p53, and ICE in EICR-If cells.
Upon acquiring CDDP resistance, sensitivity to mitomycin and adriamycin decreased, but sensitivity to etoposide and 5-fluorouracil increased.
The findings indicate that the mechanisms of CDDP resistance are different in the three cell lines.
KeywordsEndometrial cancer Cisplatin (CDDP) Multidrug resistance
- 1.Tominaga S et al. Cancer mortality and morbidity statistics. Tokyo: Japan Scientific Societies; 1994.Google Scholar
- 15.Bradley G, Juranka PF, Ling V. Mechanism of multidrug resistance. Biochim Biophys Acta. 1998;948:87–128.Google Scholar
- 22.Sriram R, Ali-Osman F, Livingston R, et al. Modulation of topoisomerase (Topo) II on the kinetics of formation and repair of cis-platinum (cis-DDP) in human tumor cells sensitive and resistant to cis-DDP. Proc Am Assoc Cancer Res. 1990;31:335.Google Scholar